10.1016/j.tins.2024.04.003 41 ZoltanU.StefanoT.TamasK.WrenJ
Department of Health and Human Services, accessed January 30, 2025, BIOLIFE and logo are registered trademarks of Baxalta Incorporated
Your BMI Our medication is conveniently delivered from a state-licensed pharmacy within our network, straight to your door when you need it
How GLP-1 drugs may be leading to new eating disorders While other weight-loss drugs have caused similar problems, one expert said GLP-1 medications have a far greater impact Bookmark CommentsGo to comments As millions of Americans take GLP1 medications like Ozempic, Wegovy and Mounjaro for weight loss or diabetes, doctors are noticing that some patients are developing previously unrecognized eating disorders due to the drugs powerful appetite-suppressing effects
[3] These studies also suggest that DSIP could attenuate the excitatory actions of NMDA receptors, further contributing to its sleep-promoting properties
This approach isnt about masking symptoms or pushing through discomfort
